| Authors: |
Louveau B; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital APHP, Paris, France.; Université de Paris, INSERM U976, Team 1, Human Immunology Pathophysiology and Immunotherapy (HIPI), Saint Louis Hospital APHP, Paris, France., Resche-Rigon M; Department of Biostatistics, Saint Louis Hospital APHP, Paris, France.; Université de Paris, INSERM U1153, Saint Louis Hospital APHP, Paris, France., Lesimple T; Oncodermatology Unit, Eugene Marquis Center, CHU CLCC, Rennes, France., Da Meda L; Department of Dermatology, Saint Louis Hospital APHP, Paris, France.; Centre d'Investigation Clinique (CIC 1427), Saint Louis Hospital APHP, Paris, France., Pracht M; Oncodermatology Unit, Eugene Marquis Center, CHU CLCC, Rennes, France., Baroudjian B; Université de Paris, INSERM U976, Team 1, Human Immunology Pathophysiology and Immunotherapy (HIPI), Saint Louis Hospital APHP, Paris, France.; Department of Dermatology, Saint Louis Hospital APHP, Paris, France., Delyon J; Université de Paris, INSERM U976, Team 1, Human Immunology Pathophysiology and Immunotherapy (HIPI), Saint Louis Hospital APHP, Paris, France.; Department of Dermatology, Saint Louis Hospital APHP, Paris, France., Amini-Adle M; CHU Lyon, Lyon, France., Dutriaux C; INSERM U1035, Université de Bordeaux, Bordeaux, France., Reger de Moura C; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital APHP, Paris, France., Sadoux A; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital APHP, Paris, France., Jouenne F; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital APHP, Paris, France.; Université de Paris, INSERM U976, Team 1, Human Immunology Pathophysiology and Immunotherapy (HIPI), Saint Louis Hospital APHP, Paris, France., Ghrieb Z; Centre d'Investigation Clinique (CIC 1427), Saint Louis Hospital APHP, Paris, France., Vilquin P; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital APHP, Paris, France.; Université de Paris, INSERM U976, Team 1, Human Immunology Pathophysiology and Immunotherapy (HIPI), Saint Louis Hospital APHP, Paris, France., Bouton D; DRCI, APHP, Paris, France., Tibi A; AGEPS, APHP, Paris, France., Huguet S; Institut Curie, Saint Cloud, France., Rezai K; Institut Curie, Saint Cloud, France., Battistella M; Université de Paris, INSERM U976, Team 1, Human Immunology Pathophysiology and Immunotherapy (HIPI), Saint Louis Hospital APHP, Paris, France.; Department of Pathology, APHP Saint Louis Hospital, Paris, France., Mourah S; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital APHP, Paris, France.; Université de Paris, INSERM U976, Team 1, Human Immunology Pathophysiology and Immunotherapy (HIPI), Saint Louis Hospital APHP, Paris, France., Lebbe C; Université de Paris, INSERM U976, Team 1, Human Immunology Pathophysiology and Immunotherapy (HIPI), Saint Louis Hospital APHP, Paris, France. celeste.lebbe@aphp.fr.; Department of Dermatology, Saint Louis Hospital APHP, Paris, France. |
